Hyderabad (Telangana) [India], May 17 (ANI): The DRDO's new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy's labs.
New Delhi [India], May 17 (ANI): The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said on Monday.
New Delhi [India], May 17 (ANI): After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh here, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need. While the drug shall be made available to
New Delhi [India], May 17 (ANI): After releasing the first batch of anti-COVID drug 2-DG developed by the Defence Research and Development Organisation (DRDO), Defence Minister Rajnath Singh on Monday termed the drug as a new ray of hope and said this is a great example of India's scienti
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh on Monday lauded the Defence Research and Development Organisation (DRDO) for developing 2-deoxy-D-glucose (2-DG) drug for the treatment of COVID-19.
New Delhi [India], May 17 (ANI): Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
New Delhi [India], May 15 (ANI): To meet the demand of oxygen supply in the country amidst the COVID-19 pandemic, India's Defence Research and Development Organisation (DRDO) has chartered the National Carrier Air India (AI) to import 'Zeolite' from different countries.
New Delhi [India], May 15 (ANI): The first batch of 10,000 doses of 2DG medicine for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday.
New Delhi [India], May 12 (ANI): German ambassador Walter J Lindner on Wednesday inaugurated the oxygen plant in Delhi's Sardar Vallabhbhai Patel DRDO Covid Hospital and said that the coronavirus can be defeated with the combined effort of India, Germany and other countries.
New Delhi [India], May 12 (ANI): The PM CARES Fund has approved procurement of 1,50,000 units of Oxycare System developed by the Defence Research Development Organisation at a cost of Rs 322.5 crores, the DRDO informed on Wednesday.